SCHEMBL258956

SCHEMBL258956

O=CCCCCCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.63
TSHR P16473 2/20 0.63
NFKB1 P19838 1/20 0.63
PMP22 Q01453 1/20 0.63
MAPT P10636 3/20 0.62
ABCC4 O15439 1/20 0.62
PPARG P37231 4/20 0.56
PPARD Q03181 4/20 0.56
PPARA Q07869 4/20 0.56
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
F7 P08709 2/20 0.56
F3 P13726 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
CYP1A2 P05177 1/20 0.56
POLB P06746 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380888 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL14798059 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL274867 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL15526298 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL648618 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL2014792 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL1603841 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL1654500 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL17744969 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT
SCHEMBL174463 1.00 LMNA (0.63) LMNATSHRNFKB1PMP22MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 582 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US claimed
CN-118402522-A Mesoporous silica polylysine nano composite antibacterial agent, preparation method and application 江苏康进医疗器材有限公司 2024-07-30 CN claimed
EP-3622289-B1 METHOD AND KIT FOR THE QUANTITATIVE DETERMINATION OF BIOMARKERS IN FAECAL SAMPLES IMMUNDIAGNOSTIK AG (DE) 2023-08-23 EP claimed
EP-3488006-B1 MATERIALS AND METHODS UTILIZING BIOTIN PRODUCING MUTANT HOSTS FOR THE PRODUCTION OF 7-CARBON CHEMICALS INVISTA TEXTILES UK LTD (GB) 2023-06-07 EP claimed
US-20230102146-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) 2023-03-30 US claimed
EP-4108666-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. (CN) 2022-12-28 EP claimed
US-11505814-B2 Methods and materials for producing 7-carbon monomers INV NYLON CHEMICALS AMERICAS, LLC (US) 2022-11-22 US claimed
CN-113336768-B Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2022-08-19 CN claimed
US-11221337-B2 Method and test kit for the quantitative determination of biomarkers in fecal samples IMMUNDIAGNOSTIK AG (DE) 2022-01-11 US claimed
US-11136603-B2 Materials and methods for directing carbon flux and increased production of 7-aminoheptanoic acid or 6-aminohexanoic acid INV NYLON CHEMICALS AMERICAS, LLC (US) 2021-10-05 US claimed
JP-2002542797-A 2002-12-17 JP claimed
EP-1250377-A1 PROCESS FOR THE PREPARATION OF A POLYAMIDE DSM N.V. (NL) 2002-10-23 EP claimed
US-6403144-B1 LECITHIN ANTISTICK AGENT, NUCLEOTIDE FLAVOR ENHANCER, POLYDIMETHYLSILOXANE ANTIFOAM AGENT, RELATIVELY LOW AMOUNTS YET PROVIDE IMPROVED FLAVOR, TEXTURE AND AROMA OF COOKING OIL, COOKING SPRAY, AND SHORTENING THE PROCTER & GAMBLE CO. 2002-06-11 US claimed
US-20020045001-A1 Food preparation compositions THE J.M. SMUCKER COMPANY 2002-04-18 US claimed
EP-1176879-A1 FOOD PREPARATION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-02-06 EP claimed
WO-2001048054-A1 PROCESS FOR THE PREPARATION OF A POLYAMIDE DSM N.V. (NL) 2001-07-05 WO claimed
WO-2000065933-A1 FOOD PREPARATION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-11-09 WO claimed
EP-0325869-B1 NOVEL PROCESSES AND INTERMEDIATES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-11-25 EP claimed
US-4654435-A WITH ORGANIC COMPOUNDS HAVING BOTH A CARBOXYL GROUP AND AN ALDEHYDE GROUP NIPPON ZEON CO., LTD. (JP) 1987-03-31 US claimed
US-4612391-A Preparation of oxycarboxylic acids PHILIP MORRIS INCORPORATED (US) 1986-09-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 LMNA 2536/4885TSHR 3382/4885NFKB1 2164/4885
US-20230102146-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR LCK, ABL1, DSTYK LMNA 4857/4885TSHR 1922/4885NFKB1 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.